Additive antileukemia effects by GFI1B- and BCR–ABL-specific siRNA in advanced phase chronic myeloid leukemic cells

Chronic Myeloid Leukemia Stem Cell Biology

(2012) Leslie A. Crews et al.   Current Hematologic Malignancy Reports

Gfi1b negatively regulatesRagexpression directly and via the repression ofFoxO1

(2011) Danae Schulz et al.   JOURNAL OF EXPERIMENTAL MEDICINE

MYC in Chronic Myeloid Leukemia: Induction of Aberrant DNA Synthesis and Association with Poor Response to Imatinib

(2011) M. Albajar et al.   MOLECULAR CANCER RESEARCH

Molecular Pathogenesis of Philadelphia-Positive Chronic Myeloid Leukemia – is it all BCR-ABL?

(2010) H. Rumpold et al.   CURRENT CANCER DRUG TARGETS

Small interfering RNA against BCR-ABL transcripts sensitize mutated T315I cells to nilotinib

(2010) M. Koldehoff et al.   HAEMATOLOGICA

Chronic myeloid leukemia: mechanisms of blastic transformation

(2010) Danilo Perrotti et al.   JOURNAL OF CLINICAL INVESTIGATION

Growth factor independent 1b (Gfi1b) and a new splice variant of Gfi1b are highly expressed in patients with acute and chronic leukemia

(2009) Lothar Vassen et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Phenotypic and gene expression diversity of malignant cells in human blast crisis chronic myeloid leukemia

(2008) Masha Simanovsky et al.   DIFFERENTIATION